OOIR: Observatory of International Research

Papers

(The TQCC of Biometrical Journal is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Missing data: A statistical framework for practice	94
Making apples from oranges: Comparing noncollapsible effect estimators and their standard errors after adjustment for different covariate sets	79
Nowcasting the COVID‐19 pandemic in Bavaria	55
Stability of clinical prediction models developed using statistical or machine learning methods	28
An ensemble approach to short‐term forecast of COVID‐19 intensive care occupancy in Italian regions	27
Nowcasting fatal COVID‐19 infections on a regional level in Germany	21
On the logic of collapsibility for causal effect measures	16
An adjusted coefficient of determination (R²) for generalized linear mixed models in one go	15
Survival analysis for AdVerse events with VarYing follow‐up times (SAVVY): Rationale and statistical concept of a meta‐analytic study	15
Phases of methodological research in biostatistics—Building the evidence base for new methods	14
A comparison of methods for analysing multiple outcome measures in randomised controlled trials using a simulation study	14
Sample size and power considerations for cluster randomized trials with count outcomes subject to right truncation	13
A product‐limit estimator of the conditional survival function when cure status is partially known	13
A statistical model for the dynamics of COVID‐19 infections and their case detection ratio in 2020	13
Impact of unequal cluster sizes for GEE analyses of stepped wedge cluster randomized trials with binary outcomes	12
Accurate error control in high‐dimensional association testing using conditional false discovery rates	12
Two‐dimensional P‐spline smoothing for spatial analysis of plant breeding trials	12
Categories, components, and techniques in a modular construction of basket trials for application and further research	11
Comparing linear discriminant analysis and supervised learning algorithms for binary classification—A method comparison study	10
gBOIN‐ET: The generalized Bayesian optimal interval design for optimal dose‐finding accounting for ordinal graded efficacy and toxicity in early clinical trials	10
Pitfalls and potentials in simulation studies: Questionable research practices in comparative simulation studies allow for spurious claims of superiority of any method	9
Time‐dependent ROC curve estimation for interval‐censored data	8
Generalized pairwise comparisons for censored data: An overview	8
Meta‐analysis of diagnostic accuracy studies with multiple thresholds: Comparison of different approaches	8
Power considerations for generalized estimating equations analyses of four‐level cluster randomized trials	7

Bounds for the weight of external data in shrinkage estimation	7
A mechanistic spatio‐temporal modeling of COVID‐19 data	7
Understanding disparities in cancer prognosis: An extension of mediation analysis to the relative survival framework	7
Correct and logical causal inference for binary and time‐to‐event outcomes in randomized controlled trials	7
Quantile modeling through multivariate log‐normal/independent linear regression models with application to newborn data	7
Against the “one method fits all data sets” philosophy for comparison studies in methodological research	7
Sample size calculation for two‐arm trials with time‐to‐event endpoint for nonproportional hazards using the concept of Relative Time when inference is built on comparing Weibull distributions	7
Power and sample size for random coefficient regression models in randomized experiments with monotone missing data	7
On the role of benchmarking data sets and simulations in method comparison studies	7
Frequentist performances of Bayesian prediction intervals for random‐effects meta‐analysis	6
A parametric quantile regression approach for modelling zero‐or‐one inflated double bounded data	6
Impact of the matching algorithm on the treatment effect estimate: A neutral comparison study	6
Random‐effects meta‐analysis models for the odds ratio in the case of rare events under different data‐generating models: A simulation study	6
Bayesian time‐varying autoregressive models of COVID‐19 epidemics	6
Growth dynamics and heritability for plant high‐throughput phenotyping studies using hierarchical functional data analysis	6
Multivariate linear mixed models with censored and nonignorable missing outcomes, with application to AIDS studies	6
Using independent cross‐sectional survey data to predict post‐migration health trajectories among refugees by estimating transition probabilities and their variances	6
Maximin design of cluster randomized trials with heterogeneous costs and variances	6
Hypothesis testing in multivariate normal models with block circular covariance structures	5
Model selection characteristics when using MCP‐Mod for dose–response gene expression data	5
Simulating longitudinal data from marginal structural models using the additive hazard model	5
Combining biomarkers by maximizing the true positive rate for a fixed false positive rate	5
Bayesian variable selection for the Cox regression model with spatially varying coefficients with applications to Louisiana respiratory cancer data	5
The modified fuzzy mortality model based on the algebra of ordered fuzzy numbers	5
Robust group sequential designs for trials with survival endpoints and delayed response	5
Design aspects of COVID‐19 treatment trials: Improving probability and time of favorable events	5
Individual risk prediction: Comparing random forests with Cox proportional‐hazards model by a simulation study	5
Improving sandwich variance estimation for marginal Cox analysis of cluster randomized trials	5
High‐dimensional feature selection in competing risks modeling: A stable approach using a split‐and‐merge ensemble algorithm	4
Joint estimation of case fatality rate of COVID‐19 and power of quarantine strategy performed in Wuhan, China	4
Improved generalized raking estimators to address dependent covariate and failure‐time outcome error	4
On the relevance of prognostic information for clinical trials: A theoretical quantification	4
An approximate Bayesian approach for estimation of the instantaneous reproduction number under misreported epidemic data	4
A spatial model to jointly analyze self‐reported survey data of COVID‐19 symptoms and official COVID‐19 incidence data	4
Sample size optimization and initial allocation of the significance levels in group sequential trials with multiple endpoints	4
A note of feature screening via a rank‐based coefficient of correlation	4
Clinical risk prediction models and informative cluster size: Assessing the performance of a suicide risk prediction algorithm	4
New weighting methods when cases are only a subset of events in a nested case‐control study	4
New methods for the additive hazards model with the informatively interval‐censored failure time data	4
Toward a standardized evaluation of imputation methodology	4
Analyzing longitudinal clustered count data with zero inflation: Marginal modeling using the Conway–Maxwell–Poisson distribution	4
Misspecified modeling of subsequent waves during COVID‐19 outbreak: A change‐point growth model	4
Modeling time‐varying recruitment rates in multicenter clinical trials	4
Enhancing estimation methods for integrating probability and nonprobability survey samples with machine‐learning techniques. An application to a Survey on the impact of the COVID‐19 pandemic in Spain	4
Using mortality to predict incidence for rare and lethal cancers in very small areas	4
Bayesian analysis of one‐inflated models for elusive population size estimation	4
On optimal two‐stage testing of multiple mediators	4
M‐quantile regression shrinkage and selection via the Lasso and Elastic Net to assess the effect of meteorology and traffic on air quality	4
Comparison of normal distribution–based and nonparametric decision limits on the GH‐2000 score for detecting growth hormone misuse (doping) in sport	4
Missing data imputation in clinical trials using recurrent neural network facilitated by clustering and oversampling	4

Correcting the bias of the net benefit estimator due to right‐censored observations	4
Sensitivity and identification quantification by a relative latent model complexity perturbation in Bayesian meta‐analysis	4
Causal inference in case of near‐violation of positivity: comparison of methods	4
A gentle tutorial on accelerated parameter and confidence interval estimation for hidden Markov models using Template Model Builder	4
Estimating the optimal population upper bound for scan methods in retrospective disease surveillance	3
Optimal dynamic treatment regime estimation using information extraction from unstructured clinical text	3
A new robust Bayesian small area estimation via ‐stable model for estimating the proportion of athletic students in California	3
Cox regression analysis for distorted covariates with an unknown distortion function	3
Subclassification estimation of the weighted average treatment effect	3
A comparison of full model specification and backward elimination of potential confounders when estimating marginal and conditional causal effects on binary outcomes from observational data	3
A comparative study of in vitro dose–response estimation under extreme observations	3
Improving adaptive seamless designs through Bayesian optimization	3
A multilevel structural equation model for assessing a drug effect on a patient‐reported outcome measure in on‐demand medication data	3
Randomized ‐values for multiple testing and their application in replicability analysis	3
Bayesian estimation of two‐part joint models for a longitudinal semicontinuous biomarker and a terminal event with INLA: Interests for cancer clinical trial evaluation	3
Functional modeling of recurrent events on time‐to‐event processes	3
Asymptotic‐based bootstrap approach for matched pairs with missingness in a single arm	3
On the equivalence of one‐inflated zero‐truncated and zero‐truncated one‐inflated count data likelihoods	3
Two sensitive characteristics and their overlap with two questions per card	3
A Q‐Q plot aids interpretation of the false discovery rate	3
A hidden Markov model for continuous longitudinal data with missing responses and dropout	3
A new method for clustered survival data: Estimation of treatment effect heterogeneity and variable selection	3
Discussion on ‘Correct and logical causal inference for binary and time‐to‐event outcomes in randomized controlled trials'	3
Optimal dose‐finding for efficacy–safety models	3
Correcting for heterogeneity and non‐comparability bias in multicenter clinical trials with a rescaled random‐effect excess hazard model	3
Multiple two‐sample testing under arbitrary covariance dependency with an application in imaging mass spectrometry	3
A flexible joint model for multiple longitudinal biomarkers and a time‐to‐event outcome: With applications to dynamic prediction using highly correlated biomarkers	3
TITE‐gBOIN‐ET: Time‐to‐event generalized Bayesian optimal interval design to accelerate dose‐finding accounting for ordinal graded efficacy and toxicity outcomes	3
Statistical inference for the difference between two maximized Youden indices obtained from correlated biomarkers	3
Restricted survival benefit with right‐censored data	3
Sample size determination for comparing accuracies between two diagnostic tests under a paired design	3
Modeling and computation of multistep batch testing for infectious diseases	3
Sequential change point detection for high‐dimensional data using nonconvex penalized quantile regression	3
Semiparametric marginal methods for clustered data adjusting for informative cluster size with nonignorable zeros	3
A neutral comparison of statistical methods for analyzing longitudinally measured ordinal outcomes in rare diseases	2
Regression‐based heterogeneity analysis to identify overlapping subgroup structure in high‐dimensional data	2
D‐optimal designs of mean‐covariance models for longitudinal data	2
Expected life years compared to the general population	2
The Bayesian simulation study (BASIS) framework for simulation studies in statistical and methodological research	2
	2
Using marginal structural joint models to estimate the effect of a time‐varying treatment on recurrent events and survival: An application on arrhythmogenic cardiomyopathy	2
Bayesian design for minimizing prediction uncertainty in bivariate spatial responses with applications to air quality monitoring	2
Robust probit linear mixed models for longitudinal binary data	2
Comparison of statistical models to predict age‐standardized cancer incidence in Switzerland	2
Rectangular tolerance regions and multivariate normal reference regions in laboratory medicine	2
Monotonicity conditions for avoiding counterintuitive decisions in basket trials	2
Assurance in vaccine efficacy clinical trial design based on immunological responses	2
Exact simultaneous confidence intervals for logical selection of a biomarker cut‐point	2
A joint Bayesian framework for missing data and measurement error using integrated nested Laplace approximations	2
Statistical review of animal trials—A guideline	2
Designing multicenter individually randomized group treatment trials	2
Confirmatory adaptive group sequential designs for single‐arm phase II studies with multiple time‐to‐event endpoints	2
Penalized joint generalized estimating equations for longitudinal binary data	2
Quantifying uncertainty in method of moments estimates of the heterogeneity variance in random effects meta‐analysis	2
Monte Carlo sensitivity analysis for unmeasured confounding in dynamic treatment regimes	2
Variable selection in linear regression models: Choosing the best subset is not always the best choice	2
On the choice of timescale for other cause mortality in a competing risk setting using flexible parametric survival models	2
Semiparametric empirical likelihood inference for abundance from one‐inflated capture–recapture data	2
Simple confidence interval and region formulas for comparing diagnostic likelihood ratios under a paired design	2
Comparing algorithms for characterizing treatment effect heterogeneity in randomized trials	2
Gene–environment interaction identification via penalized robust divergence	2
Confident identification of subgroups from SNP testing in RCTs with binary outcomes	2
A unified framework for weighted parametric group sequential design	2
Synthesizing secondary data into survival analysis to improve estimation efficiency	2
Mean residual life cure models for right‐censored data with and without length‐biased sampling	2
Clustered restricted mean survival time regression	2
A zero‐inflated endemic–epidemic model with an application to measles time series in Germany	2
Deep dynamic modeling with just two time points: Can we still allow for individual trajectories?	2
Flexible cloglog links for binomial regression models as an alternative for imbalanced medical data	2
Explaining the optimistic performance evaluation of newly proposed methods: A cross‐design validation experiment	2
Joint control of consensus and evidence in Bayesian design of clinical trials	2
Blinded sample size recalculation in adaptive enrichment designs	2
Factor‐Analytic Variance–Covariance Structures for Prediction Into a Target Population of Environments	2
Type I multivariate zero‐inflated COM–Poisson regression model	2